2007
DOI: 10.1128/jb.00788-06
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of the Moraxella catarrhalis Opa-Like Protein, OlpA, Reveals a Phylogenetically Conserved Family of Outer Membrane Proteins

Abstract: Moraxella catarrhalis is a human-restricted pathogen that can cause respiratory tract infections. In this study, we identified a previously uncharacterized 24-kDa outer membrane protein with a high degree of similarity to Neisseria Opa protein adhesins, with a predicted ␤-barrel structure consisting of eight antiparallel ␤-sheets with four surface-exposed loops. In striking contrast to the antigenically variable Opa proteins, the M. catarrhalis Opa-like protein (OlpA) is highly conserved and constitutively exp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
12
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 36 publications
2
12
0
Order By: Relevance
“…Previous studies have shown that NTHi can survive within the lysosomal compartment in eukaryotic cells [51], that these NTHi cells were viable, and that intercellular residence shields the bacteria from the host immune system and antibiotics, sustaining mucosal colonization when the bacteria emerge apically [52]. Transcytosis into the submucosa is a mechanism that can shield the bacterium from mucosal host defense, and lead to bacterial replication in blood.. NTHi strain 12 has been shown to bind to α (2-3) sialic acid on the surface of M cells in the guinea pig conjunctiva and then invaded [47].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous studies have shown that NTHi can survive within the lysosomal compartment in eukaryotic cells [51], that these NTHi cells were viable, and that intercellular residence shields the bacteria from the host immune system and antibiotics, sustaining mucosal colonization when the bacteria emerge apically [52]. Transcytosis into the submucosa is a mechanism that can shield the bacterium from mucosal host defense, and lead to bacterial replication in blood.. NTHi strain 12 has been shown to bind to α (2-3) sialic acid on the surface of M cells in the guinea pig conjunctiva and then invaded [47].…”
Section: Discussionmentioning
confidence: 99%
“…The putative amino acid sequence of OlpA2 has no significant homology to the sequence of OapA in Rd KW20 [51]. OlpA2 has homology to a Moraxella catarrhalis outer membrane protein (encoded by olpA ) which is involved in adherence [52] and resistance to normal human serum [53]. …”
Section: Discussionmentioning
confidence: 99%
“…Moraxella catarrhalis outer membrane protein OlpA (Opa-like protein A; 24 kDa) [89] is related to the neisserial Opa adhesins that bind both carcinoembryonic antigen-related cell adhesion molecule (CAECAM) and heparan sulfate proteoglycan receptors. OlpA binds factor H to the bacterial surface of Moraxella and mediates resistance to the alternative pathway of complement activation [90].…”
Section: The Alternative Pathway and Inhibition By M Catarrhalismentioning
confidence: 99%
“…More recently, sustained efforts have achieved progresses in identifying more new M. catarrhalis vaccine antigens such as OlpA [97], ORF113 [98] and liposome-associated OMPs [99]. These antigens have shown the features of a vaccine antigen such as immunogenic, exposed or partially exposed to the surface, and conserved.…”
Section: M Catarrhalis Vaccine Candidatesmentioning
confidence: 99%
“…These antigens have shown the features of a vaccine antigen such as immunogenic, exposed or partially exposed to the surface, and conserved. Some of the antigens play key roles in the pathogenesis of M. catarrhalis infections such as NP colonization and complement resistance [97-99]. Further investigation of these target molecules may prove they are potential M. catarrhalis vaccine candidates.…”
Section: M Catarrhalis Vaccine Candidatesmentioning
confidence: 99%